Increased Risks For Infection And Dislocation Faced By Obese Patients Following Revision Hip Replacement Surgery
Along with age and injuries, obesity is a leading risk factor for osteoarthritis (OA), a painful and disabling joint disease. While excessive weight can aggravate the toll on almost any joint, obesity has been associated with a higher prevalence of hip OA and an increase in total hip arthroplasty (THA).
Risk Of Knee Osteoarthritis Progression May Be Reduced By Use Of A Cane
A common, incurable joint disease, osteoarthritis (OA) is the leading cause of disability in elderly people. While nearly any joint can be affected, OA most often strikes the knee, particularly the inner aspect of the tibiofemoral joint. One source of stress on this vulnerable joint compartment is the knee adduction moment, an indication of weight placement while walking.
Increase Of Hip And Knee Replacements In The U.S.
With the graying of America's Baby Boomer generation, arthritis is a growing health concern. Traditionally associated with the elderly, this common joint disease currently afflicts over 20 million men and women in the United States. To aggravate matters, arthritis is also prevalent among the overweight - which describes nearly 65 percent of our nation's adult population.
Major Boost For Primary Care Research At Keele University As National Arthritis Charity Awards 2.5m Pounds Funding, UK
A major new centre promoting research into primary care has been created at Keele University with funding of ^Alb2.5m over five years from a leading arthritis charity. The Arthritis Research Campaign National Primary Care Centre at Keele will have a direct benefit on the thousands of people in the UK who suffer from painful joint and muscle problems.
Decline In Work Disability Due To Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the joints and, in severe cases, vital organs. Marked by pain, fatigue, and loss of dexterity and mobility, RA has been strongly associated with work disability in the US. In previous studies of patients with advanced RA, 10 years in duration, the prevalence of work disability has been estimated at as high as 50 percent.
In Vioxx Studies, Merck Used Ghostwriters And Guest Authors
In medical articles and court documents about rofecoxib, it has becomeapparent that company employees or another unacknowledged authors wereoften involved in writing the clinical trial and review articles, whileprimary authorship was awarded to academically affiliated investigatorswho may have been only peripherally related to the study.
Actemra Approved In Japan To Treat Patients With Rheumatoid Arthritis
Roche announced that their alliance partner company Chugai has received approval in Japan for the use of its innovative treatment, Actemra (tocilizumab), in patients suffering from rheumatoid arthritis (RA).
Comparison Of Latest Rheumatoid Arthritis Drugs
Findings published in the open access journal BMC Musculoskeletal Disorders shows that the latest class of drugs used to treat rheumatoid arthritis (RA) are better than standard anti-inflammatories.RA is a chronic, debilitating, inflammatory disease of the joints, which is usually treated with anti-inflammatory drugs such as methotrexate or steroids.
Cartilage Repair Hope Offered By Stem Cells Tor Arthritis Sufferers
Research presented at the UK National Stem Cell Network Annual Science Meeting in Edinburgh could offer hope that bone stem cells may be harnessed to repair the damaged cartilage that is one of the main symptoms of osteoarthritis.
Dose Escalation With Enbrel R Is Significantly Lower Than Other Commonly Used Anti-TNF Agents In Patients With Rheumatoid Arthritis, DART Study, UK
New pan-European data presented at the British Society of Rheumatology's annual meeting in Liverpool demonstrate that patients treated with Enbrel (etanercept) required significantly lower dose escalation than patients treated with infliximab and adalimumab in the first 12 months of therapy.